Enhanced magnetism and suppressed magnetoelastic coupling induced by electron doping in Ca$_{1-x}$Y$_{x}$MnReO$_6$

Autor: Cavichini, A. S., Orlando, M. T., Fantini, M. C. A., Tartaglia, R., Galdino, C. W., Damay, F., Porcher, F., Granado, E.

The Ca$_2$MnReO$_6$ double perovskite is a spin-orbit-assisted Mott insulator with exotic magnetic properties, including a largely non-collinear Mn$^{2+}$ spin arrangement and nearly orthogonal coupling between such spins and the much smaller Re $5d$

Externí odkaz: http://arxiv.org/abs/2202.08220

Structural studies of mesoporous ZrO$_{2}$-CeO$_{2}$ and ZrO$_{2}$-CeO$_{2}$/SiO$_{2}$ mixed oxides for catalytical applications

Autor: Bacani, R., Martins, T. S., Lamas, D. G., Fantini, M. C. A.

In this work the synthesis of ZrO$_{2}$-CeO$_{2}$ and ZrO$_{2}$-CeO$_{2}$/SiO$_{2}$ were developed, based on the process to form ordered mesoporous materials such as SBA-15 silica. The triblock copolymer Pluronic P-123 was used as template, aiming to

Externí odkaz: http://arxiv.org/abs/1503.01963

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Thermonuclear Reaction Rate of 23Mg(p,gamma)24$Al

Autor: Herndl, H., Fantini, M., Iliades, C., Endt, P. M., Oberhummer, H.

Publikováno v: Phys.Rev.C58:1798-1803,1998

Updated stellar rates for the reaction 23Mg(p,gamma)24Al are calculated by using all available experimental information on 24Al excitation energies. Proton and gamma-ray partial widths for astrophysically important resonances are derived from shell m

Externí odkaz: http://arxiv.org/abs/nucl-th/9806018

Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

Autor: Ahmadizar F., Luxi N., Raethke M., Schmikli S., Riefolo F., Saraswati P. W., Bucsa C., Osman A., Liddiard M., Maques F. B., Petrelli G., Sonderlichova S., Thurin N. H., Villalobos F., Trifiro G., Sturkenboom M., Moretti U., Bellitto C., Ciccimarra F., Gonella L. A., Arzenton E., Chiamulera C., Lora R., Bellantuono D., Sabaini A., Firenze A., Zodda D., Guidotti F., Zappone M., Alagna B., Cutroneo P. M., Minore C., Costantino C., Vitale F., D'Alessandro G., Morreale I., Marsala L., Farinella D., Bavetta S., Fantini M. P., Reno C., Raschi E., Poluzzi E., Sapigni E., Potenza A. M., Podetti D., Nikitina V., Ricciardelli R., Mogheiseh N., Croce S., Paltrinieri B., Castellani S., Sangiorgi E., Selleri M., Lucchesi S., Catucci G., Savini D., Sacripanti C., Faccioli M., Romio M. S., Rossi L., Radici S., Negri G., Fares L., Ajolfi C., Fadda A., Chiarello A., Pieraccini F., Gavioli B., Palazzi S., Tuccori M., Vannacci A., Bonaiuti R., Ravaldi C., Lombardi N., Crescioli G., Gori F., Tessari R., Zandona E., Zanoni G., Senna G., Crivellaro M. A., Cancian M., Venturini F., Ferri M., Leonardi L., Orzetti S., Caccin E., Baldo P., Capuano A., Rafaniello C., Ferrajolo C., Pagliaro C., Mercaldo M., di Giorgio A., Tari M., Manna S., Farina G., Di Mauro C., De Carlo I., Senesi I., Pileggi C., Palleria C., Gallelli L., De Sarro G., de Sarro C., Verduci C., Papadopoli R., Trabace L., Morgese M., Schiavone S., Tucci P., Bove M., Lapi F., Cricelli C., Racagni G., Tonolo S., Fava G., Giuffrida S., Amato V., Gambera M., Montresor V., Mastropasqua D.

Background and Objectives: The European Medicine Agency extended the use of Comirnaty, Spikevax, and Nuvaxovid in paediatrics; thus, these vaccines require additional real-world safety evidence. Herein, we aimed to monitor the safety of COVID-19 vacc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::c8916ae0b4845b6e45ea4bd7d0d193b1
https://hdl.handle.net/11585/928075